Lymphatic vessel density and function in experimental bladder cancer

BMC Cancer

Volumn 7, Issue , 2007, Pages

  Saban, Marcia R ^a   Towner, Rheal ^b   Smith, Nataliya ^b   Abbott, Andrew ^b   Neeman, Michal ^c   Davis, Carole A ^a   Simpson, Cindy ^a   Maier, Julie ^b   Mémet, Sylvie ^d   Wu, Xue Ru ^e   Saban, Ricardo ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^c WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^d INSTITUT PASTEUR   (France)

^e NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; BIOTIN; BOVINE SERUM ALBUMIN; CD31 ANTIGEN; GADOLINIUM PENTETATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KI 67 ANTIGEN; UROPLAKIN; VIRUS LARGE T ANTIGEN; GLYCOPROTEIN; MEMBRANE PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG; UROPLAKIN II; XLKD1 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER CANCER; CANCER GROWTH; CONTROLLED STUDY; ENDOTHELIUM CELL; FLUID FLOW; FLUORESCENCE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LYMPH FLOW; LYMPH VESSEL; LYMPHANGIOGENESIS; LYMPHANGIOGRAPHY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PROMOTER REGION; TIME SERIES ANALYSIS; TRANSGENIC MOUSE; TUMOR VOLUME; ANIMAL; BLADDER; BLADDER TUMOR; C57BL MOUSE; CARCINOMA IN SITU; DISEASE MODEL; FLUORESCENCE MICROSCOPY; IMMUNOLOGY; LYMPHOGRAPHY; METABOLISM; METHODOLOGY; NEAR INFRARED SPECTROSCOPY; PATHOLOGY; RADIOGRAPHY;

ANIMALS; ANTIGENS, CD31; CARCINOMA IN SITU; DISEASE MODELS, ANIMAL; GLYCOPROTEINS; IMMUNOHISTOCHEMISTRY; LYMPHANGIOGENESIS; LYMPHATIC VESSELS; LYMPHOGRAPHY; MAGNETIC RESONANCE IMAGING; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROSCOPY, FLUORESCENCE; SPECTROSCOPY, NEAR-INFRARED; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 39349095092     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-7-219     Document Type: Article

References (69)

1. Ji RC Lymphatic endothelial cells, inflammatory lymphangiogenesis, and prospective players Curr Med Chem 2007, 14(22):2359-2368. 10.2174/ 092986707781745541 17896984
2. Ji RC Lymphatic endothelial cells, tumor lymphangiogenesis and metastasis: New insights into intratumoral and peritumoral lymphatics Cancer Metastasis Rev 2006, 25(4):677-694. 10.1007/s10555-006-9026-y 17160713
3. Armer J Fu MR Wainstock JM Zagar E Jacobs LK Lymphedema following breast cancer treatment, including sentinel lymph node biopsy Lymphology 2004, 37(2):73-91. 15328760
4. Armer JM The problem of post-breast cancer lymphedema: Impact and measurement issues Cancer Invest 2005, 23(1):76-83. 10.1081/ CNV-200048707 15779870
5. Pain SJ Barber RW Solanki CK Ballinger JR Britton TB Mortimer PS Purushotham AD Peters AM Short-term effects of axillary lymph node clearance surgery on lymphatic physiology of the arm in breast cancer J Appl Physiol 2005, 99(6);2345-2351. 10.1152/japplphysiol.00372.2005 16288099
6. Parkin DM Bray F Ferlay J Pisani P Estimating the world cancer burden: Globocan 2000 Int J Cancer 2001, 94(2):153-156. 10.1002/ijc.1440 11668491
7. Cancer Facts & Figures http://www.cancer.org/downloads/STT/ CAFF2007PWSecured.pdf
8. Moyano Calvo JL Ortiz Gamiz A Poyato Galan JM Gutierrez Gonzalez M Sanchez Sanchez E Alvarez-Ossorio Fernandez JL Castineiras Fernandez J [Lymphatic invasion of the bladder wall in T1 superficial bladder carcinoma. Prognostic value] Actas urologicas espanolas 2003, 27(4):260-264. 12830546
9. Trojan L Michel MS Rensch F Jackson DG Alken P Grobholz R Lymph and blood vessel architecture in benign and malignant prostatic tissue: Lack of lymphangiogenesis in prostate carcinoma assessed with novel lymphatic marker lymphatic vessel endothelial hyaluronan receptor (LYVE-1) J Urol 2004, 172(1):103-107. 10.1097/01.ju.0000128860.00639.9c 15201747
10. Fernandez MI Bolenz C Trojan L Steidler A Weiss C Alken P Grobholz R Michel MS Prognostic Implications of Lymphangiogenesis in Muscle-Invasive Transitional Cell Carcinoma of the Bladder Eur Urol 2007
11. Saban MR Memet S Jackson DG Ash J Roig AA Israel A Saban R Visualization of lymphatic vessels through NF-kB activity Blood 2004, 104(10):3228-3230. 10.1182/blood-2004-04-1428 15271802
12. Zhang ZT Pak J Shapiro E Sun TT Wu XR Urothelium-specific expression of an oncogene in transgenic mice induced the formation of carcinoma in situ and invasive transitional cell carcinoma Cancer Res 1999, 59(14):3512-3517. 10416618
13. Wu XR Urothelial tumorigenesis: A tale of divergent pathways Nat Rev Cancer 2005, 5(9):713-725. 10.1038/nrc1697 16110317
14. Dafni H Israely T Bhujwalla ZM Benjamin LE Neeman M Overexpression of vascular endothelial growth factor 165 drives peritumor interstitial convection and induces lymphatic drain: Magnetic resonance imaging, confocal microscopy, and histological tracking of triple-labeled albumin Cancer Res 2002, 62(22):6731-6739. 12438274
15. Pathak AP Artemov D Ward BD Jackson DG Neeman M Bhujwalla ZM Characterizing Extravascular Fluid Transport of Macromolecules in the Tumor Interstitium by Magnetic Resonance Imaging Cancer Research 2005, 65(4):1425. 10.1158/0008-5472.CAN-04-3682 15735030
16. Dafni H Gilead A Nevo N Eilam R Harmelin A Neeman M Modulation of the pharmacokinetics of macromolecular contrast material by avidin chase: MRI, optical, and inductively coupled plasma mass spectrometry tracking of triply labeled albumin Magn Reson Med 2003, 50(5):904-914. 10.1002/ mrm.10638 14587000
17. Schmidt-Ullrich R Memet S Lilienbaum A Feuillard J Raphael M Israel A NF-kappaB activity in transgenic mice: Developmental regulation and tissue specificity Development 1996, 122(7):2117-2128. 8681793
18. Cheng J Huang H Pak J Shapiro E Sun TT Cordon-Cardo C Waldman FM Wu XR Allelic loss of p53 gene is associated with genesis and maintenance, but not invasion, of mouse carcinoma in situ of the bladder Cancer Res 2003, 63(1):179-185. 12517796
19. Garcia-Espana A Salazar E Sun TT Wu XR Pellicer A Differential expression of cell cycle regulators in phenotypic variants of transgenically induced bladder tumors: Implications for tumor behavior Cancer Res 2005, 65(4):1150-1157. 10.1158/0008-5472.CAN-04-2074 15734997
20. Van der Auwera I Cao Y Tille JC Pepper MS Jackson DG Fox SB Harris AL Dirix LY Vermeulen PB First international consensus on the methodology of lymphangiogenesis quantification in solid human tumours Br J Cancer 2006, 95(12):1611-1625. 10.1038/sj.bjc.6603445 17117184
21. MicroBrightField, Inc http://www.mbfbioscience.com/
22. Bernard R Hypothesis testing for correlation coefficients Boston: PWS Publishers 1990
23. Saban R Simpson C Davis CA Dozmorov I Maier J Fowler B Ihnat MA Hurst RE Wershil BK Saban MR Transcription factor network downstream of protease activated receptors (PARs) modulating mouse bladder inflammation BCM Immunology 2007, 8:17. 10.1186/1471-2172-8-17
24. Nikon http://www.nikoninstruments.com/
25. Roper Scientific http://www.roperscientific.com/
26. NIS-Elements http://www.nis-elements.com/
27. Troy T Jekic-McMullen D Sambucetti L Rice B Quantitative comparison of the sensitivity of detection of fluorescent and bioluminescent reporters in animal models Mol Imaging 2004, 3(1):9-23. 10.1162/153535004773861688 15142408
28. Microsoft http://www.microsoft.com
29. Dafni H Landsman L Schechter B Kohen F Neeman M MRI and fluorescence microscopy of the acute vascular response to VEGF165: Vasodilation, hyper-permeability and lymphatic uptake, followed by rapid inactivation of the growth factor NMR Biomed 2002, 15(2):120-131. 10.1002/nbm.724 11870908
30. Nanocs http://www.nanocs.com/dextranhtm
31. Coleman N Stanley MA Expression of the myelomonocytic antigens CD36 and L1 by keratinocytes in squamous intraepithelial lesions of the cervix Hum Pathol 1994, 25(1):73-79. 10.1016/0046-8177(94)90174-0 7508885
32. Schluter C Duchrow M Wohlenberg C Becker MH Key G Flad HD Gerdes J The cell proliferation-associated antigen of antibody Ki-67: A very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins J Cell Biol 1993, 123(3):513-522. 10.1083/jcb.123.3.513 8227122
33. Limas C Bigler A Bair R Bernhart P Reddy P Proliferative activity of urothelial neoplasms: Comparison of BrdU incorporation, Ki67 expression, and nucleolar organiser regions J Clin Pathol 1993, 46(2):159-165. 501149 8459037 10.1136/jcp.46.2.159
34. http://www.omrf.org/OMRF/Core/SmallAnimalMRI.asp
35. Marchetti C Poggi P Farina A Gritti A Scelsi L Scelsi R Structure of the initial lymphatics of the human urinary bladder with invasive urothelial tumors Lymphology 1996, 29(3):118-125. 8897356
36. Scelsi R Scelsi L Gritti A Gozo M Reguzzoni M Marchetti C Structure of the lymphatic microcirculation in the human urinary bladder with different intraluminal pressure and distension Lymphology 1996, 29(2):60-66. 8823728
37. Miyata Y Kanda S Ohba K Nomata K Eguchi J Hayashida Y Kanetake H Tumor lymphangiogenesis in transitional cell carcinoma of the upper urinary tract: Association with clinicopathological features and prognosis J Urol 2006, 176(1):348-353. 10.1016/S0022-5347(06)00520-9 16753442
38. Schoppmann SF Lymphangiogenesis, inflammation and metastasis Anticancer Res 2005, 25(6C):4503-4511. 16334134
39. Joukov V Pajusola K Kaipainen A Chilov D Lahtinen I Kukk E Saksela O Kalkkinen N Alitalo K A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases Embo J 1996, 15(2):290-298. 449944 8617204
40. Jeltsch M Kaipainen A Joukov V Meng X Lakso M Rauvala H Swartz M Fukumura D Jain RK Alitalo K Hyperplasia of lymphatic vessels in VEGF-C transgenic mice Science 1997, 276(5317):1423-1425. 10.1126/ science.276.5317.1423 9162011
41. Achen MG Jeltsch M Kukk E Makinen T Vitali A Wilks AF Alitalo K Stacker SA Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4) Proc Natl Acad Sci USA 1998, 95(2);548-553. 18457 9435229 10.1073/ pnas.95.2.548
42. Lymboussaki A Achen MG Stacker SA Alitalo K Growth factors regulating lymphatic vessels Curr Top Microbiol Immunol 2000, 251:75-82. 11036761
43. Helotera H Alitalo K The VEGF family, the inside story Cell 2007, 130(4):591-592. 10.1016/j.cell.2007.08.012 17719536
44. Saaristo A Veikkola T Tammela T Enholm B Karkkainen MJ Pajusola K Bueler H Yla-Herttuala S Alitalo K Lymphangiogenic gene therapy with minimal blood vascular side effects J Exp Med 2002, 196(6):719-730. 10.1084/ jem.20020587 12235206
45. Karkkainen MJ Ferrell RE Lawrence EC Kimak MA Levinson KL McTigue MA Alitalo K Finegold DN Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema Nat Genet 2000, 25(2):153-159. 10.1038/ 75997 10835628
46. Schledzewski K Falkowski M Moldenhauer G Metharom P Kzhyshkowska J Ganss R Demory A Falkowska-Hansen B Kurzen H Ugurel S Geginat G Arnold B Goerdt S Lymphatic endothelium-specific hyaluronan receptor LYVE-1 is expressed by stabilin-1+, F4/80+, CD11b+ macrophages in malignant tumours and wound healing tissue in vivo and in bone marrow cultures in vitro: Implications for the assessment of lymphangiogenesis J Pathol 2006, 209(1):67-77. 10.1002/path.1942 16482496
47. Schoppmann SF Birner P Stockl J Kalt R Ullrich R Caucig C Kriehuber E Nagy K Alitalo K Kerjaschki D Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis Am J Pathol 2002, 161(3):947-956. 1867252 12213723
48. Skobe M Hamberg LM Hawighorst T Schirner M Wolf GL Alitalo K Detmar M Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma Am J Pathol 2001, 159(3):893-903. 1850477 11549582
49. Maruyama K Ii M Cursiefen C Jackson DG Keino H Tomita M Van Rooijen N Takenaka H D'Amore PA Stein-Streilein J Losordo DW Streilein JW Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages J Clin Invest 2005, 115(9):2363-2372. 1193872 16138190 10.1172/JCI23874
50. Schledzewski K Falkowski M Moldenhauer G Metharom P Kzhyshkowska J Ganss R Demory A Falkowska-Hansen B Kurzen H Ugurel S Geginat G Arnold B Goerdt S Lymphatic endothelium-specific hyaluronan receptor LYVE-1 is expressed by stabilin-1(+), F4/80(+), CD11b(+) macrophages in malignant tumours and wound healing tissue in vivo and in bone marrow cultures in vitro: Implications for the assessment of lymphangiogenesis J Pathol 2006.
51. Kerjaschki D The crucial role of macrophages in lymphangiogenesis J Clin Invest 2005, 115(9):2316-2319. 1193892 16138185 10.1172/JCI26354
52. Kerjaschki D Huttary N Raab I Regele H Bojarski-Nagy K Bartel G Krober SM Greinix H Rosenmaier A Karlhofer F Wick N Mazal PR Lymphatic endothelial progenitor cells contribute to de novo lymphangiogenesis in human renal transplants Nat Med 2006, 12(2):230-234. 10.1038/nm1340 16415878
53. Renyi-Vamos F Tovari J Fillinger J Timar J Paku S Kenessey I Ostoros G Agocs L Soltesz I Dome B Lymphangiogenesis correlates with lymph node metastasis, prognosis, and angiogenic phenotype in human non-small cell lung cancer Clin Cancer Res 2005, 11(20):7344-7353. 10.1158/ 1078-0432.CCR-05-1077 16243806
54. Van der Auwera I Van den Eynden GG Colpaert CG Van Laere SJ van Dam P Van Marck EA Dirix LY Vermeulen PB Tumor lymphangiogenesis in inflammatory breast carcinoma: A histomorphometric study Clin Cancer Res 2005, 11(21):7637-7642. 10.1158/1078-0432.CCR-05-1142 16278382
55. Zeng Y Opeskin K Horvath LG Sutherland RL Williams ED Lymphatic vessel density and lymph node metastasis in prostate cancer Prostate 2005, 65(3):222-230. 10.1002/pros.20288 15948136
56. Stacker SA Achen MG Jussila L Baldwin ME Alitalo K Lymphangiogenesis and cancer metastasis Nat Rev Cancer 2002, 2(8):573-583. 10.1038/nrc863 12154350
57. Oliver G Lymphatic vasculature development Nat Rev Immunol 2004, 4(1):35-45. 10.1038/nri1258 14704766
58. Padera TP Kadambi A di Tomaso E Carreira CM Brown EB Boucher Y Choi NC Mathisen D Wain J Mark EJ Munn LL Jain RK Lymphatic metastasis in the absence of functional intratumor lymphatics Science 2002, 296(5574):1883-1886. 10.1126/science.1071420 11976409
59. Neeman M Gilad AA Dafni H Cohen B Molecular imaging of angiogenesis J Magn Reson Imaging 2007, 25(1):1-12. 10.1002/jmri.20774 17139635
60. Pan D Suzuki Y Yang PC Rockson SG Indirect magnetic resonance lymphangiography to assess lymphatic function in experimental murine lymphedema Lymphatic research and biology 2006, 4(4):211-216. 10.1089/ lrb.2006.4405
61. Kajiya K Hirakawa S Detmar M Vascular endothelial growth factor-A mediates ultraviolet B-induced impairment of lymphatic vessel function The American journal of pathology 2006, 169(4):1496-1503. 1780190 17003502 10.2353/ajpath.2006.060197
62. Lohrmann C Foeldi E Bartholoma JP Langer M Magnetic resonance imaging of lymphatic vessels without image subtraction: A practicable imaging method for routine clinical practice? Journal of computer assisted tomography 2007, 31(2):303-308. 10.1097/01.rct.0000237814.33925.32 17414770
63. Barrett T Choyke PL Kobayashi H Imaging of the lymphatic system: New horizons Contrast media & molecular imaging 2006, 1(6):230-245. 10.1002/cmmi.116 17191764
64. Bellin MF Roy C Magnetic resonance lymphography Current opinion in urology 2007, 17(1):65-69. 10.1097/MOU.0b013e32801198a3 17143113
65. Ferrusi I Zhao J van Helden D von der Weid PY Cyclopiazonic acid decreases spontaneous transient depolarizations in guinea pig mesenteric lymphatic vessels in endothelium-dependent and -independent manners Am J Physiol Heart Circ Physiol 2004, 286(6):H2287-2295. 10.1152/ ajpheart.00739.2003 14975927
66. McCloskey KD Hollywood MA Thornbury KD Ward SM McHale NG Kit-like immunopositive cells in sheep mesenteric lymphatic vessels Cell Tissue Res 2002, 310(1):77-84. 10.1007/s00441-002-0623-y 12242486
67. Abcam http://www.abcam.com
68. Santa Cruz http://www.scbt.com
69. Lab Vision http://www.labvision.com